[Prevention of embolisms in atrial fibrillation: anticoagulation and antiplatelet therapy].

Abstract

Over the past five years, the results of six prospective randomized trials have set new standards in the primary and secondary prevention of thromboembolism in "nonvalvular" ("nonrheumatic") atrial fibrillation. On the one hand, they have confirmed the increased risk of stroke in these patients amounting to about 5% per year and an annual recurrence rate… (More)

Topics

Cite this paper

@article{Kienast1994PreventionOE, title={[Prevention of embolisms in atrial fibrillation: anticoagulation and antiplatelet therapy].}, author={Joachim Kienast}, journal={Zeitschrift fur Kardiologie}, year={1994}, volume={83 Suppl 5}, pages={49-58} }